MIMS COVID-19 webcast draws record turnout


Online meeting sees the participation of 3,600 healthcare professionals from across Asia Pacific

 

SINGAPORE – Media OutReach – 27 May 2020 – The MIMS Group conducted an online symposium
for Asian primary care physicians (PCPs) titled “COVID-19: What it means to
your clinic” on Friday, 8 May 2020, at 19:00 GMT+8.

The inaugural webcast of MIMS’s COVID Conversations
Series, the event saw more than 3,600 general practitioners and family doctors
log-in from 26 countries, with doctors from the Philippines, Malaysia,
Singapore, Hong Kong, and Indonesia comprising the majority of participants.

The webcast featured Professor Ivan Hung, Clinical
Professor and Chief of Infectious Diseases, Department of Medicine, Li Ka Shing
Faculty of Medicine, University of Hong Kong, as keynote presenter; and Dr.
Helmy Haja Mydin, head of The Lung Centre, Pantai Hospital Kuala Lumpur,
Malaysia, as discussant. MIMS’s Dr. Awi Curameng served as the webcast
moderator.

 

The online symposium was aimed at translating the
fast-evolving science of COVID-19 patient care into practical clinical pearls
for the Asian PCP and providing insights on how clinicians can prepare for the
next outbreak. Topics discussed included novel coronavirus transmission,
clinical presentations, high-risk populations, COVID-19 diagnosis, general
management principles, specific treatments, recommended infection control
practices, and the outlook on vaccines.

 

The MIMS COVID Conversations Series is part of MIMS’s
focused effort to provide essential COVID-19 content to the healthcare
professional community across Asia Pacific.

About MIMS

MIMS Group, a subsidiary of SMS Co. Ltd. (TYO 2175), has
been offering diverse expertise for over 50 years in 17 countries and markets
in Asia, Oceania and the Middle East with a focus on providing marketing
support services to pharmaceutical companies, clinical decision support tools
integrated with healthcare institutions as well as knowledge services to
empower healthcare professionals in their daily operations. MIMS marketing
platform services spread across 10 countries and markets mainly in South East
Asia and have over 2.5 million healthcare professionals registered on our
online platform (www.mims.com), with drug directory services, medical
communications, as well as media platform businesses.

 

MIMS has offices in the following countries & markets:

 

Singapore (Headquarters), Australia, China, Hong Kong,
Indonesia, India, Ireland, Japan, Korea, Malaysia, Myanmar, New Zealand,
Philippines, Taiwan, Thailand, United Arab Emirates, and Vietnam.

 

For more information, please visit http://corporate.mims.com

MORE FROM THIS SECTION


on Twitter, 'LIKE' us on Facebook

Comments are closed.